Patient & Survivor Care
From the Journals
Delaying palliative chemo may improve QoL without affecting survival for asymptomatic patients
For asymptomatic patients, delaying the start of systemic therapy should be discussed with the patient.
From the Journals
Financial toxicity screening can reduce cancer cost burdens
About one in five cancer survivors report experiencing financial toxicity, but financial monitoring is not a routine part of clinical care.
Latest News
Medicare announces 10 drugs targeted for price cuts in 2026
People on Medicare may in 2026 see prices drop for 10 medicines, including pricey diabetes, cancer, blood clot, and arthritis treatments.
From the Journals
No link between most cancers and depression/anxiety: Study
The findings “may help health professionals to alleviate feelings of guilt and self-blame in patients with cancer who attribute their diagnosis to...
From the Journals
Risky drinking common in cancer survivors
The numbers are “staggering. Most concerning ... is that those on cancer treatment are engaged in a similar level of risky drinking.”
From the Journals
Big geographic access gaps for oncofertility services in U.S.
“Significant geographic disparities in access to fertility preservation in the U.S. require strategic expansion of care, especially given the...
From the Journals
Liver transplant in CRC: Who might benefit?
“It seems likely that there is a small group of patients with unresectable colorectal liver metastases who should be considered for transplant,...
From the Journals
Alcohol consumption may not influence breast cancer prognosis, study
The findings could help in developing specific guidelines related to the prevention of breast cancer recurrence and death in survivors.
From the Journals
Female CRC survivors may experience long-term GI symptoms
“Our findings shed light on the importance of psychosocial support as well as lifestyle interventions (specifically nutritional management) in...
From the Journals
Survival, QoL trump PFS for most patients with cancer
“The results of our study demonstrate that more than half of patients with advanced cancer would not want a treatment that delays time to...
From the Journals
Anticoagulants for cancer-related VTE: What works best?
These data may “help facilitate shared decision-marking and inform clinical guidelines for the treatment of such patients.”